Pages that link to "Q34247109"
Jump to navigation
Jump to search
The following pages link to Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up (Q34247109):
Displaying 50 items.
- Hyperinsulinemia. A link between hypertension obesity and glucose intolerance (Q24564030) (← links)
- Drug-induced diabetes (Q28165384) (← links)
- Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies (Q30668690) (← links)
- Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects (Q33561456) (← links)
- Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. (Q33781944) (← links)
- Influence of West African Ethnicity and Gender on Beta-Cell Function and Insulin Sensitivity in Essential Hypertensives Treated with Hydrochlorothiazide and Hydrochlorothiazide-lisinopril Combination (Q33872249) (← links)
- Serum potassium and cardiovascular mortality (Q33928343) (← links)
- Defects in insulin action in chronic heart failure (Q34166305) (← links)
- The effects of anti-hypertensive medication on learning and memory (Q34403514) (← links)
- Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability (Q34421109) (← links)
- Essential hypertension (Q34664767) (← links)
- Role of nifedipine in treatment of hypertension (Q34994533) (← links)
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials (Q35107962) (← links)
- New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial (Q35580146) (← links)
- Is the development of diabetes with antihypertensive therapy a problem?--Pro (Q36392685) (← links)
- Prediabetes and cardiovascular risk in hypertensive patients (Q36467532) (← links)
- Metabolic considerations in the choice of therapy for the patient with hypertension (Q36482909) (← links)
- Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial (Q36506245) (← links)
- The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis (Q36682346) (← links)
- Hypertension in non-insulin dependent diabetes mellitus and its management (Q36682361) (← links)
- Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE) (Q36707701) (← links)
- Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension (Q36886618) (← links)
- Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension (Q36945027) (← links)
- Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan (Q37104853) (← links)
- Abnormal cation exchange in insulin-resistant patients with essential hypertension (Q37683744) (← links)
- Antihypertensive therapy. Is it different in the elderly? (Q37925774) (← links)
- ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role? (Q37932368) (← links)
- Thiazides in the 1990s (Q37949165) (← links)
- Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II). (Q37977342) (← links)
- Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions (Q38253580) (← links)
- Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (Q38618657) (← links)
- Hypertension in the diabetic patient. Selection and optimum use of antihypertensive drugs (Q38723230) (← links)
- Sulphonylureas in the treatment of non-insulin-dependent diabetes (Q39578390) (← links)
- Diuretic therapy and exercise performance (Q39667779) (← links)
- Drug use and increased HbA1c levels in non-diabetic very elderly persons: the Kungsholmen project (Q39678407) (← links)
- The elderly patient. A special case for diuretic therapy (Q39739051) (← links)
- Diuretics. Clinical pharmacology and therapeutic use (Part II). (Q39816368) (← links)
- Effects of Antihypertensive Drugs on Endocrine Function (Q40094048) (← links)
- Do Non-Potassium-Sparing Diuretics Increase the Risk of Sudden Cardiac Death in Hypertensive Patients? (Q40391892) (← links)
- Diltiazem: Ten Years of Clinical Experience in the Treatment of Hypertension (Q40442992) (← links)
- Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients. (Q40449514) (← links)
- Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review (Q40696805) (← links)
- The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years (Q40877474) (← links)
- Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels? (Q41118641) (← links)
- Adverse metabolic effects of antihypertensive drugs. Implications for treatment (Q41128714) (← links)
- The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities (Q41431021) (← links)
- Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy (Q41431049) (← links)
- Current status of diuretics, beta-blockers, alpha-blockers, and alpha-beta-blockers in the treatment of hypertension (Q41632434) (← links)
- Soluble Fiber and Hypertension (Q41636989) (← links)
- Glucose and cholesterol elevations during thiazide therapy: Intention-to-treat versus actual on-therapy experience (Q41681669) (← links)